Rex Merchant
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Rex Merchant
Rex Merchant was last confirmed as CFO at Anebulo Pharmaceuticals, Inc. (ANEB) in a filing dated October 17, 2022. The proxy statement of Anebulo Pharmaceuticals, Inc. reports total compensation of $275,000 for Rex Merchant in fiscal 2022, including a base salary of $275,000. Disclosed compensation is on record for 2 fiscal years.
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Start not stated–2022-10-17
Last confirmed by a filing; no departure on record
Company network
Recorded roles and call appearances connecting this person to public companies.
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2022 | Anebulo Pharmaceuticals, Inc. (ANEB) | Chief Financial Officer | $275,000 | $275,000 |
| 2021 | Anebulo Pharmaceuticals, Inc. (ANEB) | Chief Financial Officer | $119,792 | $119,792 |
Recent activity
No call appearances or filed executive changes recorded yet.